Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal protein binding	XIRP1 SHROOM3 SPATA31A3 ABI3BP RPS3 SPATA31A7 APC WHAMM SPATA31C1 SPATA31A5 AFAP1 SPATA31A1 KCNC1 CCT5 XIRP2 TTLL11 PAK1 RAB11FIP5 ROCK1 PLEKHH2 MYO16	4.38e-07	1099	109	21	GO:0008092
GeneOntologyMolecularFunction	actin binding	XIRP1 SHROOM3 SPATA31A3 ABI3BP SPATA31A7 WHAMM SPATA31C1 SPATA31A5 AFAP1 SPATA31A1 XIRP2 PLEKHH2 MYO16	2.13e-06	479	109	13	GO:0003779
GeneOntologyMolecularFunction	mRNA 5'-UTR binding	LARP1 CCT5 GNL3	3.33e-04	25	109	3	GO:0048027
GeneOntologyBiologicalProcess	positive regulation of JUN kinase activity	RPS3 MAGI3 FCER1A PAK1 MAP3K10	6.23e-06	49	110	5	GO:0043507
GeneOntologyBiologicalProcess	positive regulation of molecular function	AGAP5 PPRC1 RPS3 MAGI3 SRCIN1 STOX1 ARHGAP11A FASLG FCER1A BTK ARID5B PAK1 MAP3K10 ROCK1 FGFR3 TAF1 BCAR3 AGAP9 AGAP7P AGAP4 AGAP6	1.91e-05	1430	110	21	GO:0044093
GeneOntologyBiologicalProcess	regulation of JUN kinase activity	RPS3 MAGI3 FCER1A PAK1 MAP3K10	2.92e-05	67	110	5	GO:0043506
GeneOntologyBiologicalProcess	positive regulation of catalytic activity	AGAP5 RPS3 MAGI3 SRCIN1 STOX1 ARHGAP11A FASLG FCER1A PAK1 MAP3K10 ROCK1 FGFR3 BCAR3 AGAP9 AGAP7P AGAP4 AGAP6	3.06e-05	1028	110	17	GO:0043085
GeneOntologyBiologicalProcess	positive regulation of hydrolase activity	AGAP5 RPS3 ARHGAP11A FASLG ROCK1 FGFR3 BCAR3 AGAP9 AGAP7P AGAP4 AGAP6	7.34e-05	499	110	11	GO:0051345
GeneOntologyCellularComponent	anchoring junction	XIRP1 SHROOM3 RPS3 TRPC4 APC MAGI3 PARD3B SRCIN1 LCP2 CCDC85A KIAA1210 AFAP1 XIRP2 TJP1 PAK1 FGFR3 PEAK1 BCAR3 PDZD2	8.65e-07	976	111	19	GO:0070161
GeneOntologyCellularComponent	B-WICH complex	BAZ1B DDX21 DEK	8.00e-06	8	111	3	GO:0110016
GeneOntologyCellularComponent	cell-cell junction	XIRP1 SHROOM3 TRPC4 APC MAGI3 PARD3B LCP2 CCDC85A KIAA1210 TJP1 PAK1 PDZD2	7.21e-05	591	111	12	GO:0005911
GeneOntologyCellularComponent	acrosomal vesicle	ENKUR SPATA31A3 SPATA31A7 SPATA31C1 SPATA31A5 KIAA1210 SPATA31A1	1.16e-04	206	111	7	GO:0001669
GeneOntologyCellularComponent	focal adhesion	XIRP1 RPS3 SRCIN1 AFAP1 XIRP2 PAK1 FGFR3 PEAK1 BCAR3	4.90e-04	431	111	9	GO:0005925
GeneOntologyCellularComponent	cell-substrate junction	XIRP1 RPS3 SRCIN1 AFAP1 XIRP2 PAK1 FGFR3 PEAK1 BCAR3	5.97e-04	443	111	9	GO:0030055
GeneOntologyCellularComponent	postsynaptic density	SHANK1 SYN3 ABI3BP RPS3 PCLO SRCIN1 PAK6 PAK1 EIF3A	6.78e-04	451	111	9	GO:0014069
GeneOntologyCellularComponent	cell cortex	SHROOM3 PCLO TRPC4 APC PARD3B STOX1 KCNC3 PLEKHH2	8.24e-04	371	111	8	GO:0005938
GeneOntologyCellularComponent	adherens junction	XIRP1 SHROOM3 APC PARD3B CCDC85A TJP1	9.48e-04	212	111	6	GO:0005912
GeneOntologyCellularComponent	actin cytoskeleton	XIRP1 SHROOM3 SRCIN1 AFAP1 XIRP2 TJP1 PAK1 PEAK1 PLEKHH2 MYO16	9.95e-04	576	111	10	GO:0015629
GeneOntologyCellularComponent	asymmetric synapse	SHANK1 SYN3 ABI3BP RPS3 PCLO SRCIN1 PAK6 PAK1 EIF3A	1.01e-03	477	111	9	GO:0032279
GeneOntologyCellularComponent	cell leading edge	ABI3BP RPS3 APC SRCIN1 KCNC1 KCNC3 PAK1 ROCK1 PLEKHH2	1.39e-03	500	111	9	GO:0031252
GeneOntologyCellularComponent	lamellipodium	ABI3BP APC SRCIN1 PAK1 ROCK1 PLEKHH2	1.44e-03	230	111	6	GO:0030027
GeneOntologyCellularComponent	postsynaptic specialization	SHANK1 SYN3 ABI3BP RPS3 PCLO SRCIN1 PAK6 PAK1 EIF3A	1.45e-03	503	111	9	GO:0099572
GeneOntologyCellularComponent	apical junction complex	SHROOM3 APC MAGI3 PARD3B TJP1	1.56e-03	158	111	5	GO:0043296
GeneOntologyCellularComponent	neuron to neuron synapse	SHANK1 SYN3 ABI3BP RPS3 PCLO SRCIN1 PAK6 PAK1 EIF3A	1.90e-03	523	111	9	GO:0098984
GeneOntologyCellularComponent	microtubule	SHROOM3 ENKUR DYNC2H1 APC WHAMM NCKAP5 CCT5 TTLL11 EIF3A	2.16e-03	533	111	9	GO:0005874
MousePheno	fused cornea and lens	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	2.70e-07	24	84	5	MP:0001307
MousePheno	abnormal jaw morphology	DOCK1 AGAP5 ABI3BP TTC28 DYNC2H1 APC BAZ1B MAST4 ARID5B FGFR3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	5.22e-07	530	84	15	MP:0000454
MousePheno	abnormal viscerocranium morphology	DOCK1 AGAP5 ABI3BP TTC28 DYNC2H1 APC BAZ1B MAST4 ARID5B FGFR3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	2.13e-06	593	84	15	MP:0005274
MousePheno	abnormal snout morphology	DOCK1 AGAP5 BAZ1B ARID5B KCNQ3 FGFR3 AGAP9 AGAP7P AGAP4 AGAP6	3.10e-06	257	84	10	MP:0000443
MousePheno	abnormal lens development	AGAP5 BCAR3 AGAP9 AGAP7P AGAP4 AGAP6	7.14e-06	78	84	6	MP:0005545
MousePheno	abnormal tooth morphology	AGAP5 ABI3BP BAZ1B MAST4 FGFR3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	2.00e-05	318	84	10	MP:0002100
MousePheno	abnormal dental arch morphology	AGAP5 ABI3BP BAZ1B MAST4 FGFR3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	2.06e-05	319	84	10	MP:0030254
MousePheno	abnormal cranium morphology	DOCK1 AGAP5 SHROOM3 ABI3BP TTC28 DYNC2H1 APC BAZ1B MAST4 ARID5B FGFR3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	2.27e-05	813	84	16	MP:0000438
MousePheno	abnormal facial morphology	DOCK1 AGAP5 SHROOM3 ENKUR ABI3BP DYNC2H1 BAZ1B MAST4 ARID5B KCNQ3 FGFR3 WDFY3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	2.37e-05	910	84	17	MP:0003743
MousePheno	abnormal head morphology	DOCK1 AGAP5 SHROOM3 ENKUR ABI3BP DYNC2H1 APC LARP1 BAZ1B MAST4 ARID5B KCNQ3 FGFR3 WDFY3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	2.77e-05	1120	84	19	MP:0000432
MousePheno	abnormal craniofacial bone morphology	DOCK1 AGAP5 SHROOM3 ABI3BP TTC28 DYNC2H1 APC BAZ1B MAST4 ARID5B FGFR3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	2.80e-05	827	84	16	MP:0002116
MousePheno	abnormal mouth morphology	AGAP5 SHROOM3 ABI3BP DYNC2H1 BAZ1B MAST4 ARID5B FGFR3 WDFY3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	4.15e-05	670	84	14	MP:0000452
MousePheno	abnormal craniofacial morphology	DOCK1 AGAP5 SHROOM3 ENKUR ABI3BP TTC28 DYNC2H1 APC LARP1 BAZ1B MAST4 ARID5B KCNQ3 ANKMY2 FGFR3 WDFY3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	4.44e-05	1372	84	21	MP:0000428
MousePheno	craniofacial phenotype	DOCK1 AGAP5 SHROOM3 ENKUR ABI3BP TTC28 DYNC2H1 APC LARP1 BAZ1B MAST4 ARID5B KCNQ3 ANKMY2 FGFR3 WDFY3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	4.44e-05	1372	84	21	MP:0005382
MousePheno	increased circulating potassium level	AGAP5 USP31 AGAP9 AGAP7P AGAP4 AGAP6	8.70e-05	121	84	6	MP:0005627
MousePheno	abnormal skin coloration	RAG1 AGAP5 PAK6 AGAP9 AGAP7P AGAP4 AGAP6	1.10e-04	182	84	7	MP:0011239
MousePheno	abnormal iris morphology	AGAP5 JMJD1C BCAR3 AGAP9 AGAP7P AGAP4 AGAP6	1.53e-04	192	84	7	MP:0001322
MousePheno	abnormal potassium level	AGAP5 WHAMM USP31 AGAP9 AGAP7P AGAP4 AGAP6	1.74e-04	196	84	7	MP:0020887
MousePheno	malocclusion	BAZ1B MAST4 FGFR3 PEAK1	1.78e-04	47	84	4	MP:0000120
MousePheno	abnormal potassium ion homeostasis	AGAP5 WHAMM USP31 AGAP9 AGAP7P AGAP4 AGAP6	1.85e-04	198	84	7	MP:0011978
MousePheno	abnormal anterior uvea morphology	AGAP5 JMJD1C BCAR3 AGAP9 AGAP7P AGAP4 AGAP6	1.91e-04	199	84	7	MP:0005194
MousePheno	absent pinna reflex	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	1.94e-04	89	84	5	MP:0006358
MousePheno	misaligned teeth	BAZ1B MAST4 FGFR3 PEAK1	2.64e-04	52	84	4	MP:0030540
MousePheno	abnormal skin morphology	SHANK1 RAG1 AGAP5 ENKUR CEBPE APC LARP1 PAK6 FASLG BAP1 CCT5 XIRP2 TTLL11 ROCK1 ANKMY2 WDFY3 AGAP9 AGAP7P AGAP4 AGAP6	3.06e-04	1455	84	20	MP:0002060
MousePheno	abnormal pinna reflex	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	3.50e-04	101	84	5	MP:0001485
MousePheno	increased granulosa cell tumor incidence	ATAD5 BAP1	3.53e-04	5	84	2	MP:0012411
MousePheno	increased neocortex size	ARHGAP11A WDFY3	5.27e-04	6	84	2	MP:0020067
MousePheno	abnormal circulating potassium level	AGAP5 USP31 AGAP9 AGAP7P AGAP4 AGAP6	5.67e-04	171	84	6	MP:0002668
MousePheno	abnormal uvea morphology	AGAP5 JMJD1C BCAR3 AGAP9 AGAP7P AGAP4 AGAP6	6.08e-04	241	84	7	MP:0005197
Domain	Ankyrin_rpt-contain_dom	SHANK1 AGAP5 TRPC4 ANKRD34B ANKMY2 ANKRD24 AGAP9 AGAP7P AGAP4 AGAP6 MYO16	2.56e-07	254	108	11	IPR020683
Domain	ANK_REP_REGION	SHANK1 AGAP5 TRPC4 ANKRD34B ANKMY2 ANKRD24 AGAP9 AGAP7P AGAP4 AGAP6 MYO16	2.56e-07	254	108	11	PS50297
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31C1 SPATA31A5	5.05e-07	12	108	4	PF15371
Domain	DUF4599	SPATA31A3 SPATA31A7 SPATA31C1 SPATA31A5	5.05e-07	12	108	4	IPR027970
Domain	ArfGap	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	6.26e-07	29	108	5	SM00105
Domain	ArfGap	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	6.26e-07	29	108	5	PF01412
Domain	ARFGAP	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	6.26e-07	29	108	5	PS50115
Domain	ArfGAP	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	6.26e-07	29	108	5	IPR001164
Domain	-	SHANK1 AGAP5 TRPC4 ANKRD34B ANKMY2 ANKRD24 AGAP9 AGAP4 AGAP6 MYO16	1.76e-06	248	108	10	1.25.40.20
Domain	ANK	SHANK1 AGAP5 TRPC4 ANKRD34B ANKMY2 ANKRD24 AGAP7P AGAP4 AGAP6 MYO16	1.96e-06	251	108	10	SM00248
Domain	ANK_REPEAT	SHANK1 AGAP5 TRPC4 ANKRD34B ANKMY2 ANKRD24 AGAP7P AGAP4 AGAP6 MYO16	2.11e-06	253	108	10	PS50088
Domain	PDZ	SHANK1 SHROOM3 PCLO MAGI3 PARD3B MAST4 TJP1 PDZD2	2.70e-06	151	108	8	PS50106
Domain	PDZ	SHANK1 SHROOM3 PCLO MAGI3 PARD3B MAST4 TJP1 PDZD2	2.83e-06	152	108	8	IPR001478
Domain	Ankyrin_rpt	SHANK1 AGAP5 TRPC4 ANKRD34B ANKMY2 ANKRD24 AGAP7P AGAP4 AGAP6 MYO16	2.88e-06	262	108	10	IPR002110
Domain	PH	AGAP5 IRS1 AFAP1 BTK ROCK1 AGAP9 AGAP7P PLEKHH2 AGAP4 AGAP6	4.88e-06	278	108	10	SM00233
Domain	PH_DOMAIN	AGAP5 IRS1 AFAP1 BTK ROCK1 AGAP9 AGAP7P PLEKHH2 AGAP4 AGAP6	5.03e-06	279	108	10	PS50003
Domain	PH_domain	AGAP5 IRS1 AFAP1 BTK ROCK1 AGAP9 AGAP7P PLEKHH2 AGAP4 AGAP6	5.19e-06	280	108	10	IPR001849
Domain	PDZ	SHANK1 SHROOM3 MAGI3 PARD3B MAST4 TJP1 PDZD2	1.78e-05	141	108	7	PF00595
Domain	PDZ	SHANK1 SHROOM3 MAGI3 PARD3B MAST4 TJP1 PDZD2	2.43e-05	148	108	7	SM00228
Domain	-	SHANK1 SHROOM3 MAGI3 PARD3B MAST4 TJP1 PDZD2	2.65e-05	150	108	7	2.30.42.10
Domain	XIRP1/XIRP2	XIRP1 XIRP2	3.31e-05	2	108	2	IPR030072
Domain	Actin-binding_Xin_repeat	XIRP1 XIRP2	3.31e-05	2	108	2	IPR012510
Domain	XIN	XIRP1 XIRP2	3.31e-05	2	108	2	PS51389
Domain	Xin	XIRP1 XIRP2	3.31e-05	2	108	2	PF08043
Domain	Ank_2	SHANK1 AGAP5 ANKRD34B ANKMY2 ANKRD24 AGAP4 AGAP6 MYO16	3.55e-05	215	108	8	PF12796
Domain	PH_dom-like	AGAP5 IRS1 AFAP1 BTK ROCK1 WDFY3 AGAP9 AGAP7P PLEKHH2 AGAP4 AGAP6	3.62e-05	426	108	11	IPR011993
Domain	Ank	SHANK1 TRPC4 ANKRD34B ANKMY2 ANKRD24 AGAP7P AGAP4 MYO16	5.38e-05	228	108	8	PF00023
Domain	K_chnl_volt-dep_Kv3	KCNC1 KCNC3	1.97e-04	4	108	2	IPR003974
Domain	PH	IRS1 AFAP1 BTK ROCK1 AGAP7P PLEKHH2 AGAP4	3.71e-04	229	108	7	PF00169
Domain	Bromodomain_CS	BAZ1B BRPF1 TAF1	4.44e-04	26	108	3	IPR018359
Domain	-	AGAP5 IRS1 AFAP1 BTK ROCK1 AGAP9 PLEKHH2 AGAP4 AGAP6	4.45e-04	391	108	9	2.30.29.30
Domain	WASP_C	PAK6 PAK1	6.83e-04	7	108	2	IPR011026
Domain	VG_K_chnl	KCNC1 KCNC3 KCNQ3	9.04e-04	33	108	3	IPR028325
Domain	BROMODOMAIN_1	BAZ1B BRPF1 TAF1	1.27e-03	37	108	3	PS00633
Domain	Bromodomain	BAZ1B BRPF1 TAF1	1.37e-03	38	108	3	PF00439
Domain	TPR_7	TTC28 RPAP3	1.45e-03	10	108	2	PF13176
Domain	BROMODOMAIN_2	BAZ1B BRPF1 TAF1	1.71e-03	41	108	3	PS50014
Domain	BROMO	BAZ1B BRPF1 TAF1	1.83e-03	42	108	3	SM00297
Domain	Bromodomain	BAZ1B BRPF1 TAF1	1.83e-03	42	108	3	IPR001487
Domain	-	BAZ1B BRPF1 TAF1	1.83e-03	42	108	3	1.20.920.10
Domain	PBD	PAK6 PAK1	3.77e-03	16	108	2	SM00285
Domain	Kinase-like_dom	CHD9 PAK6 MAST4 BTK PAK1 MAP3K10 ROCK1 FGFR3 PEAK1	4.20e-03	542	108	9	IPR011009
Domain	PBD	PAK6 PAK1	4.26e-03	17	108	2	PF00786
Domain	Ion_trans_dom	TRPC4 KCNC1 KCNC3 KCNQ3	4.33e-03	114	108	4	IPR005821
Domain	Ion_trans	TRPC4 KCNC1 KCNC3 KCNQ3	4.33e-03	114	108	4	PF00520
Domain	PROTEIN_KINASE_ATP	PAK6 MAST4 BTK PAK1 MAP3K10 ROCK1 FGFR3 PEAK1	5.18e-03	459	108	8	PS00107
Pathway	SIG_CHEMOTAXIS	PAK6 BTK PAK1 ROCK1	6.36e-05	45	68	4	M5193
Pathway	WP_REGULATION_OF_ACTIN_CYTOSKELETON	DOCK1 APC PAK6 PAK1 ROCK1 FGFR3	8.35e-05	150	68	6	M39520
Pathway	WP_REGULATION_OF_ACTIN_CYTOSKELETON	DOCK1 APC PAK6 PAK1 ROCK1 FGFR3	8.98e-05	152	68	6	MM15834
Pubmed	The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.	SPATA31A3 SPATA31A7 SPATA31C1 SPATA31A5 SPATA31A1	1.98e-12	6	113	5	20850414
Pubmed	Targeted disruption of the spermatid-specific gene Spata31 causes male infertility.	SPATA31A3 SPATA31A7 SPATA31C1 SPATA31A5 SPATA31A1	1.98e-12	6	113	5	25930072
Pubmed	GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins.	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	4.13e-11	9	113	5	12640130
Pubmed	AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	8.24e-11	10	113	5	20664521
Pubmed	AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase.	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	1.51e-10	11	113	5	15381706
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP36 AGAP5 SHROOM3 LARP1 SRCIN1 ARHGAP11A BAP1 AFAP1 MAST4 CCT5 RAB11FIP5 AGAP9 AGAP7P AGAP4 AGAP6	2.05e-10	529	113	15	14621295
Pubmed	The Endosome Localized Arf-GAP AGAP1 Modulates Dendritic Spine Morphology Downstream of the Neurodevelopmental Disorder Factor Dysbindin.	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	4.17e-10	13	113	5	27713690
Pubmed	GTP-binding protein-like domain of AGAP1 is protein binding site that allosterically regulates ArfGAP protein catalytic activity.	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	6.48e-10	14	113	5	22453919
Pubmed	A human MAP kinase interactome.	SHANK1 DOCK1 SUPT20H ABI3BP APC NCKAP5 PAK6 LCP2 BTK PAK1 MAP3K10 ANKRD24 EIF3A TAF1	6.99e-10	486	113	14	20936779
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	AGAP5 PCLO SRCIN1 AFAP1 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6 MYO16	2.69e-09	218	113	10	33378226
Pubmed	Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.	SPATA31A3 SPATA31A7 SPATA31C1 SPATA31A5 SPATA31A1	1.34e-08	24	113	5	32212159
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SHROOM3 TTC28 APC LARP1 MAGI3 PARD3B IRS1 FAM98A PAK6 MLXIP USP31 MAST4 TJP1 MAP3K10 RAB11FIP5 PEAK1	2.05e-08	861	113	16	36931259
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	USP36 ATAD5 RPS3 LARP1 BAZ1B FAM98A JMJD1C YEATS2 TINF2 TJP1 DDX3Y TAF1 ZCCHC7 DDX21 DEK GNL3	8.38e-08	954	113	16	36373674
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	AGAP5 APC LARP1 MAGI3 FAM98A STOX1 AGAP9 AGAP7P AGAP4 AGAP6 GNL3	1.71e-07	430	113	11	32581705
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SHANK1 SUPT20H TTC28 PPRC1 APC WHAMM MAGI3 CHD9 NCKAP5 SLC4A3 CCDC85A TJP1 ARID5B PAK1 MAP3K10 ANKRD24 TAF1 WDFY3	1.78e-07	1285	113	18	35914814
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	USP36 SUPT20H ATAD5 EI24 BAZ1B MLXIP ARHGAP11A JMJD1C BAP1 YEATS2 TINF2 ARID5B ISG20L2 ZCCHC7 MED17 DDX21 DEK GNL3	1.97e-07	1294	113	18	30804502
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TTC28 RPAP3 RPS3 LARP1 BAZ1B JMJD1C YEATS2 CCT5 TJP1 TAF1 PEAK1 MED17	2.47e-07	549	113	12	38280479
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	DOCK1 TTC28 RPAP3 RPS3 APC LARP1 MAGI3 JMJD1C CCT5 RAB11FIP5 ROCK1 PEAK1 MED17	5.49e-07	708	113	13	39231216
Pubmed	Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.	DOCK1 SUPT20H RPAP3 RPS3 CCT5 DDX3Y ROCK1 TAF1 MED17 DEK	6.24e-07	390	113	10	17643375
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	SUPT20H DYNC2H1 PCLO APC LARP1 JMJD1C YEATS2 ARID5B ROCK1 TAF1	7.50e-07	398	113	10	35016035
Pubmed	Shroom3 functions downstream of planar cell polarity to regulate myosin II distribution and cellular organization during neural tube closure.	SHROOM3 TJP1 ROCK1	1.16e-06	7	113	3	25596276
Pubmed	Distinct strategies to make nucleosomal DNA accessible.	BAZ1B DDX21 DEK	1.85e-06	8	113	3	12769854
Pubmed	Nuclear myosin 1 contributes to a chromatin landscape compatible with RNA polymerase II transcription activation.	BAZ1B DDX21 DEK	1.85e-06	8	113	3	26044184
Pubmed	Oncogenic functions of protein kinase D2 and D3 in regulating multiple cancer-related pathways in breast cancer.	AGAP5 SLC4A3 TJP1 AGAP9 AGAP4 AGAP6	2.28e-06	116	113	6	30652415
Pubmed	Nuclear myosin 1c facilitates the chromatin modifications required to activate rRNA gene transcription and cell cycle progression.	BAZ1B DDX21 DEK	2.77e-06	9	113	3	23555303
Pubmed	The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription.	BAZ1B DDX21 DEK	2.77e-06	9	113	3	16603771
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SHANK1 SYN3 PRR36 RPS3 PCLO APC LARP1 FAM98A SRCIN1 USP31 AFAP1 CCT5 TJP1 KCNQ3 DDX3Y EIF3A PEAK1	3.81e-06	1431	113	17	37142655
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	SHANK1 AGAP5 PCLO SRCIN1 AGAP9 AGAP7P AGAP4 AGAP6	4.04e-06	281	113	8	28706196
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	SHROOM3 TTC28 RPAP3 APC MAGI3 PARD3B MLXIP MAST4 CCT5 TJP1 BRPF1 MINDY4 GNL3	4.27e-06	853	113	13	28718761
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF449 DOCK1 SHROOM3 LARP1 MAGI3 CHD9 PARD3B SRCIN1 JMJD1C YEATS2 TULP4 TJP1 TTLL11 ARID5B ANKRD24 GNL3 PDZD2	6.43e-06	1489	113	17	28611215
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	USP36 BAP1 USP31 TJP1 MINDY4 VPS53	8.96e-06	147	113	6	29576527
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	DOCK1 AGAP5 SHROOM3 JMJD1C WDFY3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	1.04e-05	536	113	10	15840001
Pubmed	Presynaptic Kv3 channels are required for fast and slow endocytosis of synaptic vesicles.	KCNC1 KCNC3	1.05e-05	2	113	2	33508244
Pubmed	Motor dysfunction and altered synaptic transmission at the parallel fiber-Purkinje cell synapse in mice lacking potassium channels Kv3.1 and Kv3.3.	KCNC1 KCNC3	1.05e-05	2	113	2	12930807
Pubmed	Kv3 potassium channels control the duration of different arousal states by distinct stochastic and clock-like mechanisms.	KCNC1 KCNC3	1.05e-05	2	113	2	16553620
Pubmed	Emergence of Xin demarcates a key innovation in heart evolution.	XIRP1 XIRP2	1.05e-05	2	113	2	18682726
Pubmed	Oral interleukin-10 alleviates polyposis via neutralization of pathogenic T-regulatory cells.	RAG1 APC	1.05e-05	2	113	2	25228656
Pubmed	Kv3.3 subunits control presynaptic action potential waveform and neurotransmitter release at a central excitatory synapse.	KCNC1 KCNC3	1.05e-05	2	113	2	35510987
Pubmed	Canonical transient receptor potential channel 4 (TRPC4) co-localizes with the scaffolding protein ZO-1 in human fetal astrocytes in culture.	TRPC4 TJP1	1.05e-05	2	113	2	15540229
Pubmed	Behavioral motor dysfunction in Kv3-type potassium channel-deficient mice.	KCNC1 KCNC3	1.05e-05	2	113	2	16923152
Pubmed	Active Rho kinase (ROK-alpha ) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells.	IRS1 ROCK1	1.05e-05	2	113	2	11739394
Pubmed	PAK1 promotes intestinal tumor initiation.	APC PAK1	1.05e-05	2	113	2	26304465
Pubmed	Subcellular localization of the voltage-gated potassium channels Kv3.1b and Kv3.3 in the cerebellar dentate nucleus of glutamic acid decarboxylase 67-green fluorescent protein transgenic mice.	KCNC1 KCNC3	1.05e-05	2	113	2	18682278
Pubmed	Depletion of p21-activated kinase 1 up-regulates the immune system of APC∆14/+ mice and inhibits intestinal tumorigenesis.	APC PAK1	1.05e-05	2	113	2	28629331
Pubmed	Ablation of Kv3.1 and Kv3.3 potassium channels disrupts thalamocortical oscillations in vitro and in vivo.	KCNC1 KCNC3	1.05e-05	2	113	2	18495891
Pubmed	Increased motor drive and sleep loss in mice lacking Kv3-type potassium channels.	KCNC1 KCNC3	1.05e-05	2	113	2	15005717
Pubmed	Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.	RAG1 BTK	1.05e-05	2	113	2	34323286
Pubmed	Spinocerebellar ataxia-13 Kv3.3 potassium channels: arginine-to-histidine mutations affect both functional and protein expression on the cell surface.	KCNC1 KCNC3	1.05e-05	2	113	2	23734863
Pubmed	Rescue of motor coordination by Purkinje cell-targeted restoration of Kv3.3 channels in Kcnc3-null mice requires Kcnc1.	KCNC1 KCNC3	1.05e-05	2	113	2	20016089
Pubmed	Purkinje-cell-restricted restoration of Kv3.3 function restores complex spikes and rescues motor coordination in Kcnc3 mutants.	KCNC1 KCNC3	1.05e-05	2	113	2	18448641
Pubmed	Effect of EI24 expression on the tumorigenesis of ApcMin/+ colorectal cancer mouse model.	EI24 APC	1.05e-05	2	113	2	31097220
Pubmed	Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics.	CEBPE ARID5B	1.05e-05	2	113	2	23836053
Pubmed	Allele-dependent changes of olivocerebellar circuit properties in the absence of the voltage-gated potassium channels Kv3.1 and Kv3.3.	KCNC1 KCNC3	1.05e-05	2	113	2	15217387
Pubmed	Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.	APC FASLG	1.05e-05	2	113	2	17510409
Pubmed	Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3.	KCNC1 KCNC3	1.05e-05	2	113	2	11517255
Pubmed	The Xin repeat-containing protein, mXinβ, initiates the maturation of the intercalated discs during postnatal heart development.	XIRP1 XIRP2	1.05e-05	2	113	2	23261932
Pubmed	Structure, Expression, and Function of a Novel Intercalated Disc Protein, Xin.	XIRP1 XIRP2	1.05e-05	2	113	2	16708114
Pubmed	Fas ligand expression on T cells is sufficient to prevent prolonged airway inflammation in a murine model of asthma.	RAG1 FASLG	1.05e-05	2	113	2	19855087
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	DOCK1 AGAP5 SHROOM3 JMJD1C WDFY3 PEAK1 AGAP9 AGAP7P AGAP4 AGAP6	1.08e-05	538	113	10	10512203
Pubmed	Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.	ABI3BP SPATA31A7 LARP1 RAB11FIP5 EIF3A DDX21	1.26e-05	156	113	6	22952844
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	SUPT20H RPAP3 LARP1 BAZ1B JMJD1C YEATS2 TJP1 PAK1 RAB11FIP5	1.54e-05	444	113	9	34795231
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP36 SUPT20H TTC28 ATAD5 BAZ1B CHD9 YEATS2 BRPF1 RAB11FIP5 TRAF3IP3 TAF1 WDFY3 VPS53 GNL3	1.62e-05	1116	113	14	31753913
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	SHROOM3 APC PARD3B IRS1 ARHGAP11A	2.15e-05	102	113	5	15778465
Pubmed	Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease.	ENKUR RPAP3 PAK6 XIRP2	2.35e-05	51	113	4	24510904
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	USP36 ATAD5 RPS3 LARP1 BAZ1B FAM98A EIF3A DDX21 DEK GNL3	2.94e-05	605	113	10	28977666
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ATAD5 BAZ1B CHD9 ARHGAP11A JMJD1C BAP1 BRPF1 TAF1 DEK GNL3	3.06e-05	608	113	10	36089195
Pubmed	ARID5B, CEBPE and PIP4K2A Germline Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia in Mexican Patients: A MIGICCL Study.	CEBPE ARID5B	3.13e-05	3	113	2	28476190
Pubmed	Absence of Tec family kinases interleukin-2 inducible T cell kinase (Itk) and Bruton's tyrosine kinase (Btk) severely impairs Fc epsilonRI-dependent mast cell responses.	FCER1A BTK	3.13e-05	3	113	2	21212279
Pubmed	T-cell Expression of IL10 Is Essential for Tumor Immune Surveillance in the Small Intestine.	RAG1 APC	3.13e-05	3	113	2	25855122
Pubmed	Integrin engagement differentially modulates epithelial cell motility by RhoA/ROCK and PAK1.	PAK1 ROCK1	3.13e-05	3	113	2	15611088
Pubmed	Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group.	CEBPE ARID5B	3.13e-05	3	113	2	24497567
Pubmed	Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells.	FASLG ROCK1	3.13e-05	3	113	2	18084615
Pubmed	Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.	CEBPE ARID5B	3.13e-05	3	113	2	25761407
Pubmed	A functional role for Smad7 in sustaining colon cancer cell growth and survival.	RAG1 APC	3.13e-05	3	113	2	24556688
Pubmed	TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression.	APC IRS1	3.13e-05	3	113	2	30679431
Pubmed	The scaffold protein POSH regulates axon outgrowth.	SHROOM3 ROCK1	3.13e-05	3	113	2	18829867
Pubmed	Xin repeats define a novel actin-binding motif.	XIRP1 XIRP2	3.13e-05	3	113	2	15454575
Pubmed	Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.	CEBPE ARID5B	3.13e-05	3	113	2	19684604
Pubmed	Perforin is a major contributor to NK cell control of tumor metastasis.	RAG1 FASLG	3.13e-05	3	113	2	10352283
Pubmed	Association of Genetic Variants in ARID5B, IKZF1 and CEBPE with Risk of Childhood de novo B-Lineage Acute Lymphoblastic Leukemia in India.	CEBPE ARID5B	3.13e-05	3	113	2	27644650
Pubmed	Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population.	CEBPE ARID5B	3.13e-05	3	113	2	23608171
Pubmed	Kv3 channels contribute to the delayed rectifier current in small cultured mouse dorsal root ganglion neurons.	KCNC1 KCNC3	3.13e-05	3	113	2	22673617
Pubmed	Filamin C is a highly dynamic protein associated with fast repair of myofibrillar microdamage.	XIRP1 XIRP2	3.13e-05	3	113	2	27206985
Pubmed	A novel and evolutionarily conserved PtdIns(3,4,5)P3-binding domain is necessary for DOCK180 signalling.	DOCK1 PAK1	3.13e-05	3	113	2	16025104
Pubmed	Structure of Shroom domain 2 reveals a three-segmented coiled-coil required for dimerization, Rock binding, and apical constriction.	SHROOM3 ROCK1	3.13e-05	3	113	2	22493320
Pubmed	Expression and significance of Rac1, Pak1 and Rock1 in gastric carcinoma.	PAK1 ROCK1	3.13e-05	3	113	2	23298303
Pubmed	Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming.	RAG1 APC	3.13e-05	3	113	2	21303980
Pubmed	Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin-Frankfurt-Münster Study Group.	CEBPE ARID5B	3.13e-05	3	113	2	25005032
Pubmed	A combined laser microdissection and mass spectrometry approach reveals new disease relevant proteins accumulating in aggregates of filaminopathy patients.	XIRP1 XIRP2	3.13e-05	3	113	2	23115302
Pubmed	P21-activated kinase 1 promotes colorectal cancer survival by up-regulation of hypoxia-inducible factor-1α.	APC PAK1	3.13e-05	3	113	2	23811286
Pubmed	Mechanism and function of Vav1 localisation in TCR signalling.	RAG1 LCP2	3.13e-05	3	113	2	22956543
Pubmed	Pre-B cell receptor signaling induces immunoglobulin κ locus accessibility by functional redistribution of enhancer-mediated chromatin interactions.	RAG1 BTK	3.13e-05	3	113	2	24558349
Pubmed	Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood.	CEBPE ARID5B	3.13e-05	3	113	2	20042726
Pubmed	Activation loop dynamics determine the different catalytic efficiencies of B cell- and T cell-specific tec kinases.	RAG1 BTK	3.13e-05	3	113	2	23982207
Pubmed	Shroom3-mediated recruitment of Rho kinases to the apical cell junctions regulates epithelial and neuroepithelial planar remodeling.	SHROOM3 ROCK1	3.13e-05	3	113	2	18339671
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DYNC2H1 MAGI3 JMJD1C CCDC85A TULP4 ANKRD24 EIF3A PEAK1 PLEKHH2	3.48e-05	493	113	9	15368895
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	SHANK1 MAGI3 PAK6 TULP4 TJP1 MAP3K10	4.68e-05	197	113	6	36604605
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	LARP1 JMJD1C YEATS2 CCT5 PDZD2	5.27e-05	123	113	5	26912792
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	RPS3 APC LARP1 CHD9 IRS1 TULP4 CCT5 TJP1 TTLL11 PAK1 DDX3Y MED17 DDX21 GNL3	5.43e-05	1247	113	14	27684187
Pubmed	Identification of new ciliary signaling pathways in the brain and insights into neurological disorders.	AGAP5 PAK6 SLC4A3 KCNQ3 AGAP9 AGAP7P AGAP4 AGAP6	5.57e-05	405	113	8	38187761
Interaction	YWHAE interactions	SHROOM3 SYN3 TTC28 RPAP3 RPS3 APC LARP1 PARD3B IRS1 SRCIN1 PAK6 MLXIP LCP2 BAP1 USP31 MAST4 MAP3K10 RAB11FIP5 ROCK1 EIF3A MINDY4 PEAK1 DDX21	2.41e-07	1256	110	23	int:YWHAE
Interaction	SFN interactions	SHROOM3 RPAP3 RPS3 APC LARP1 PARD3B IRS1 ARHGAP11A BAP1 USP31 MAST4 TJP1 MAP3K10 PEAK1 ZCCHC7 DEK	1.09e-06	692	110	16	int:SFN
Interaction	YWHAZ interactions	SHROOM3 TTC28 APC LARP1 PARD3B IRS1 PAK6 MLXIP LCP2 BAP1 USP31 MAST4 ANKRD34B TJP1 PAK1 MAP3K10 RAB11FIP5 EIF3A WDFY3 PEAK1 ZCCHC7 DEK	2.19e-06	1319	110	22	int:YWHAZ
Interaction	YWHAB interactions	SHROOM3 TTC28 RPAP3 APC LARP1 PARD3B IRS1 PAK6 MLXIP BAP1 USP31 MAST4 TJP1 MAP3K10 RAB11FIP5 FGFR3 PEAK1 ZCCHC7	9.12e-06	1014	110	18	int:YWHAB
Interaction	YWHAG interactions	SHROOM3 TTC28 RPAP3 APC LARP1 MAGI3 PARD3B IRS1 FAM98A PAK6 MLXIP BAP1 USP31 MAST4 TINF2 TJP1 PAK1 MAP3K10 RAB11FIP5 PEAK1	1.23e-05	1248	110	20	int:YWHAG
Interaction	H3C1 interactions	USP36 RAG1 SUPT20H DYNC2H1 ATAD5 LARP1 BAZ1B ARHGAP11A JMJD1C XIRP2 BRPF1 PAK1 TAF1 DEK GNL3 PDZD2	3.02e-05	901	110	16	int:H3C1
Interaction	AATF interactions	USP36 RPS3 LARP1 CCT5 TJP1 ISG20L2 EIF3A ZCCHC7 DDX21 GNL3	4.06e-05	376	110	10	int:AATF
Interaction	POLR1G interactions	USP36 RPAP3 ATAD5 TRPC4 CHD9 BAP1 BRPF1 ISG20L2 TAF1 DDX21 GNL3	7.53e-05	489	110	11	int:POLR1G
Interaction	PRKD2 interactions	AGAP5 SLC4A3 BAP1 TJP1 AGAP9 AGAP4 AGAP6 NXPH3	7.72e-05	254	110	8	int:PRKD2
Interaction	KCNA3 interactions	DOCK1 TTC28 RPAP3 RPS3 APC LARP1 MAGI3 CHD9 JMJD1C YEATS2 CCT5 RAB11FIP5 ROCK1 PEAK1 MED17	7.74e-05	871	110	15	int:KCNA3
Interaction	YWHAH interactions	SHROOM3 TTC28 APC LARP1 MAGI3 PARD3B IRS1 FAM98A PAK6 MLXIP BAP1 USP31 MAST4 TJP1 MAP3K10 RAB11FIP5 PEAK1	9.65e-05	1102	110	17	int:YWHAH
Cytoband	10q11.23	VSTM4 AGAP7P AGAP6	7.71e-05	33	114	3	10q11.23
Cytoband	Ensembl 112 genes in cytogenetic band chr10q11	VSTM4 AGAP9 AGAP7P AGAP4 AGAP6	1.12e-04	188	114	5	chr10q11
Cytoband	2q36	IRS1 SLC4A3	1.69e-04	8	114	2	2q36
Cytoband	Ensembl 112 genes in cytogenetic band chr9q12	SPATA31A7 SPATA31A5	1.69e-04	8	114	2	chr9q12
Cytoband	1q23	FASLG FCER1A	1.49e-03	23	114	2	1q23
Cytoband	9p13.1	SPATA31A3 SPATA31A1	1.63e-03	24	114	2	9p13.1
Cytoband	13q13.3	SUPT20H TRPC4	2.38e-03	29	114	2	13q13.3
GeneFamily	Ankyrin repeat domain containing	SHANK1 AGAP5 TRPC4 ANKRD34B ANKMY2 ANKRD24 AGAP9 AGAP7P AGAP4 AGAP6 MYO16	9.15e-09	242	80	11	403
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	AGAP5 IRS1 AFAP1 BTK ROCK1 AGAP9 AGAP7P PLEKHH2 AGAP4 AGAP6	2.44e-08	206	80	10	682
GeneFamily	ArfGAPs	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	3.22e-07	33	80	5	395
GeneFamily	PDZ domain containing	SHANK1 SHROOM3 PCLO MAGI3 PARD3B MAST4 TJP1 PDZD2	3.60e-07	152	80	8	1220
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	AGAP5 AGAP9 AGAP4 AGAP6	8.10e-07	17	80	4	1291
GeneFamily	Potassium voltage-gated channels	KCNC1 KCNC3 KCNQ3	7.32e-04	40	80	3	274
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	MAGI3 TJP1	5.87e-03	26	80	2	904
Coexpression	THEODOROU_MAMMARY_TUMORIGENESIS	AGAP5 JMJD1C AGAP9 AGAP7P AGAP4 AGAP6	1.05e-08	37	111	6	MM1121
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	DOCK1 SUPT20H TTC28 APC BAZ1B CHD9 IRS1 ARHGAP11A AFAP1 ARID5B ROCK1 ANKMY2 EIF3A WDFY3 BCAR3 DDX21 DEK	1.20e-07	856	111	17	M4500
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	1.18e-06	44	111	5	MM485
Coexpression	GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN	ZNF449 BEND5 WHAMM STOX1 MAP3K10 KCNQ3 BCAR3	2.28e-05	199	111	7	M7853
Coexpression	GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN	PPRC1 FAM98A LCP2 CCT5 ARID5B DDX21 GNL3	2.28e-05	199	111	7	M7454
Coexpression	GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP	LARP1 LCP2 TINF2 TJP1 ARID5B PAK1 PEAK1	2.36e-05	200	111	7	M3913
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	PPRC1 BAZ1B CHD9 IRS1 MAST4 ARID5B WDFY3 BCAR3	4.27e-05	300	111	8	M8702
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	TTC28 PCLO CHD9 NCKAP5 MAST4 WDFY3 PDZD2	4.45e-05	221	111	7	M39222
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5	ABI3BP PAK6 LCP2 IGSF10 VSTM4 ARID5B RAB11FIP5 TRAF3IP3 PEAK1	1.28e-05	276	109	9	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3	ABI3BP LCP2 IGSF10 VSTM4 ARID5B RAB11FIP5 TRAF3IP3 PEAK1	4.38e-05	249	109	8	Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	RPAP3 DYNC2H1 ATAD5 ROCK1 EIF3A FGFR3 DEK	6.06e-05	192	109	7	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	ABI3BP TTC28 BEND5 LCP2 IGSF10 VSTM4 ARID5B RAB11FIP5 ROCK1 ANKRD24 EIF3A PEAK1 PLEKHH2	1.14e-04	744	109	13	Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4
CoexpressionAtlas	kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000	SHROOM3 TTC28 DYNC2H1 ATAD5 PCLO LARP1 BCAT2 NCKAP5 IRS1 FAM98A ARHGAP11A PLEKHH2 PDZD2	1.22e-04	749	109	13	gudmap_kidney_P3_CapMes_Crym_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2	ABI3BP BEND5 LCP2 IGSF10 VSTM4 ARID5B RAB11FIP5 PEAK1	1.27e-04	290	109	8	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	DYNC2H1 ATAD5 PCLO NCKAP5 TJP1 EIF3A FGFR3 DEK	1.53e-04	298	109	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4	ABI3BP LCP2 IGSF10 VSTM4 ARID5B RAB11FIP5 TRAF3IP3 PEAK1	1.53e-04	298	109	8	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	SYN3 PRR36 RPAP3 DYNC2H1 ATAD5 PCLO BAZ1B NCKAP5 AFAP1 PAK1 ROCK1 EIF3A FGFR3 DEK GNL3	1.60e-04	989	109	15	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	PRR36 ATAD5 PCLO APC BAZ1B PAK6 LCP2 C6orf136 ROCK1 EIF3A TAF1 WDFY3 PEAK1 MED17 DEK	1.60e-04	989	109	15	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3	ABI3BP BEND5 LCP2 IGSF10 VSTM4 ARID5B RAB11FIP5 TRAF3IP3 PEAK1	1.64e-04	384	109	9	Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	PRR36 RPAP3 DYNC2H1 ATAD5 PCLO NCKAP5 ROCK1 EIF3A FGFR3 DEK	2.47e-04	498	109	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5	ABI3BP LCP2 IGSF10 VSTM4 ARID5B RAB11FIP5 ROCK1 PEAK1	3.11e-04	331	109	8	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	SYN3 RPAP3 DYNC2H1 ATAD5 PCLO BAZ1B NCKAP5 AFAP1 PAK1 EIF3A FGFR3 DEK VPS53	3.36e-04	831	109	13	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM3 MAGI3 PARD3B NCKAP5 CCDC85A TJP1 PEAK1 MYO16 PDZD2	1.09e-09	184	113	9	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM3 MAGI3 PARD3B NCKAP5 CCDC85A TJP1 PEAK1 MYO16 PDZD2	1.09e-09	184	113	9	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	SHROOM3 MAGI3 PARD3B NCKAP5 CCDC85A TJP1 PEAK1 MYO16 PDZD2	1.26e-09	187	113	9	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	SHROOM3 MAGI3 PARD3B NCKAP5 CCDC85A TJP1 MYO16 PDZD2	1.29e-08	170	113	8	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 ABI3BP MAGI3 NCKAP5 CCDC85A TJP1 MYO16 PDZD2	1.92e-08	179	113	8	4f6ca313b78aa93557937a046c44dcf8bcc9963c
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	SHROOM3 MAGI3 PARD3B NCKAP5 CCDC85A TJP1 MYO16 PDZD2	2.38e-08	184	113	8	561592edc3083fad41b91811151b442207c65dd9
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABI3BP DYNC2H1 IGSF10 VSTM4 AFAP1 ARID5B PLEKHH2 MYO16	4.05e-08	197	113	8	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 SHROOM3 TTC28 MAGI3 PARD3B WDFY3 PEAK1 PDZD2	4.21e-08	198	113	8	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABI3BP DYNC2H1 IGSF10 AFAP1 ARID5B MINDY4 PLEKHH2 MYO16	4.55e-08	200	113	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	SHROOM3 MAGI3 NCKAP5 CCDC85A TJP1 MYO16 PDZD2	3.14e-07	174	113	7	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	SHROOM3 MAGI3 PARD3B NCKAP5 CCDC85A KCNQ3 PDZD2	3.80e-07	179	113	7	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APC BAZ1B CHD9 JMJD1C EIF3A ZCCHC7 DDX21	4.57e-07	184	113	7	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 MAGI3 NCKAP5 CCDC85A TJP1 MYO16 PDZD2	4.74e-07	185	113	7	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	SHROOM3 MAGI3 PARD3B NCKAP5 CCDC85A KCNQ3 PEAK1	4.74e-07	185	113	7	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 MAGI3 NCKAP5 CCDC85A TJP1 MYO16 PDZD2	5.68e-07	190	113	7	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SHROOM3 TTC28 PARD3B NCKAP5 JMJD1C MAST4 PDZD2	6.09e-07	192	113	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM3 MAGI3 PARD3B NCKAP5 MAST4 KCNQ3 PDZD2	6.53e-07	194	113	7	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 SHROOM3 TTC28 MAGI3 PARD3B ZCCHC7 PDZD2	6.99e-07	196	113	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	ABI3BP DYNC2H1 CHD9 IGSF10 DDX3Y PLEKHH2 MYO16	7.24e-07	197	113	7	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABI3BP DYNC2H1 IGSF10 AFAP1 PEAK1 PLEKHH2 MYO16	7.74e-07	199	113	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	ABI3BP TTC28 DYNC2H1 ARID5B MINDY4 PLEKHH2 MYO16	8.01e-07	200	113	7	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	AT1-AT2_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	MAGI3 BCAT2 NCKAP5 CCDC85A PLEKHH2 PDZD2	5.69e-06	175	113	6	bdd85ba280648a0283c1984662a34c7b840f64dd
ToppCell	systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DOCK1 NCKAP5 FCER1A KCNC3 PAK1 DDX3Y	5.69e-06	175	113	6	c58a1f02d1e559d3638fe1500e960e82a8a7187b
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM3 MAGI3 IGSF10 DDX3Y PLEKHH2 MYO16	6.07e-06	177	113	6	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	6.68e-06	180	113	6	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	6.68e-06	180	113	6	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	6.90e-06	181	113	6	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	ABI3BP PCLO MAGI3 NCKAP5 CCDC85A PLEKHH2	7.35e-06	183	113	6	6821dca076318115d360ff426eb1218cfe104063
ToppCell	Control-Epithelial-Club\|World / Disease state, Lineage and Cell class	SHROOM3 MAGI3 NCKAP5 MAST4 TJP1 FGFR3	8.06e-06	186	113	6	9798428691408e17ff2af2fe2d1b345f074d67e4
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	SHROOM3 MAGI3 NCKAP5 CCDC85A TJP1 MYO16	8.06e-06	186	113	6	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	COPD-Stromal-Pericyte\|Stromal / Disease state, Lineage and Cell class	TRPC4 NCKAP5 KCNC3 TJP1 KCNQ3 PDZD2	8.31e-06	187	113	6	406ecd1dabb3ed8d871aef159f7bd1e383434953
ToppCell	AT1-AT2_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	ABI3BP MAGI3 BCAT2 NCKAP5 CCDC85A TJP1	8.57e-06	188	113	6	be710bc957118cf426dd71c2d57e6f1b41c9a467
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	8.83e-06	189	113	6	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	8.83e-06	189	113	6	e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRPC4 SLC4A3 AFAP1 ANKRD34B KCNC1 MYO16	8.83e-06	189	113	6	78cf414b98bcb19deb934409acddaad1cd51b67f
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	SHROOM3 MAGI3 NCKAP5 CCDC85A TJP1 PDZD2	8.83e-06	189	113	6	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RAG1 CHD9 MLXIP JMJD1C ARID5B ZCCHC7	9.10e-06	190	113	6	f623f0bdece6002b68ac2207e99408b24a2b1194
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	9.10e-06	190	113	6	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	9.38e-06	191	113	6	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RAG1 BEND5 CHD9 MLXIP ARID5B ZCCHC7	9.38e-06	191	113	6	054fa0493b00149313c243d39cf39a264044f074
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	9.66e-06	192	113	6	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	9.66e-06	192	113	6	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	9.66e-06	192	113	6	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP TTC28 VSTM4 AFAP1 PLEKHH2 MYO16	9.66e-06	192	113	6	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	SHROOM3 MAGI3 PARD3B MAST4 KCNQ3 PDZD2	9.66e-06	192	113	6	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	9.66e-06	192	113	6	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	9.66e-06	192	113	6	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	9.95e-06	193	113	6	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	RAG1 CHD9 MLXIP JMJD1C ARID5B ZCCHC7	1.02e-05	194	113	6	f64da5f62e29253d60b9546edf734ba5c17daae1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	1.02e-05	194	113	6	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	1.02e-05	194	113	6	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABI3BP IGSF10 VSTM4 AFAP1 PLEKHH2 MYO16	1.02e-05	194	113	6	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCKAP5 SLC4A3 FCER1A KCNC3 BTK PAK1	1.06e-05	195	113	6	4cbc36fb3ef9aef61367d3b37070a9a85fae1418
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SHROOM3 MAGI3 PARD3B NCKAP5 MAST4 PDZD2	1.06e-05	195	113	6	9406866f99555198a9be311fbd65751b70f35446
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC28 DYNC2H1 PCLO TULP4 DDX3Y ZCCHC7	1.06e-05	195	113	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ABI3BP PARD3B IGSF10 MAST4 ARID5B PLEKHH2	1.12e-05	197	113	6	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 MAGI3 NCKAP5 MAST4 KCNC3 FGFR3	1.15e-05	198	113	6	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	AT1-AT2_cells\|World / lung cells shred on cell class, cell subclass, sample id	SHROOM3 MAGI3 BCAT2 NCKAP5 CCDC85A TJP1	1.15e-05	198	113	6	a5b3617ea2ed4bffba59edcf6284799c2b3bbb29
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCKAP5 SLC4A3 FCER1A KCNC3 BTK PAK1	1.15e-05	198	113	6	d0371e2ca9e25727b35985940f6228f9d8e49727
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NCKAP5 SLC4A3 FCER1A KCNC3 BTK PAK1	1.15e-05	198	113	6	08ad0bece508bb4f9cc126d94839b5c89ce21ba8
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHROOM3 MAGI3 NCKAP5 MAST4 KCNC3 FGFR3	1.15e-05	198	113	6	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABI3BP IGSF10 AFAP1 ARID5B PLEKHH2 MYO16	1.18e-05	199	113	6	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	Enterocyte_Progenitors\|World / shred on cell type and cluster	RPS3 MLXIP ARID5B DDX21 DEK GNL3	1.18e-05	199	113	6	776bcc887927dea9ebd76ec4338ce2225c319c2c
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABI3BP IGSF10 AFAP1 ARID5B PLEKHH2 MYO16	1.18e-05	199	113	6	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	control-cDC\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	NCKAP5 SLC4A3 FCER1A KCNC3 BTK PAK1	1.18e-05	199	113	6	31825ba336603fe940dea6022e18ec25af110f4c
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABI3BP DYNC2H1 IGSF10 AFAP1 PLEKHH2 MYO16	1.18e-05	199	113	6	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	ABI3BP AFAP1 ARID5B MINDY4 PLEKHH2 MYO16	1.18e-05	199	113	6	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK1 TTC28 MAGI3 PARD3B WDFY3 ZCCHC7	1.18e-05	199	113	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	SHROOM3 PCLO IRS1 ARID5B ROCK1 DEK	1.18e-05	199	113	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ABI3BP IGSF10 AFAP1 ARID5B PLEKHH2 MYO16	1.18e-05	199	113	6	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ABI3BP IGSF10 AFAP1 ARID5B PLEKHH2 MYO16	1.18e-05	199	113	6	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	ABI3BP AFAP1 ARID5B MINDY4 PLEKHH2 MYO16	1.18e-05	199	113	6	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	Macroglial-Astrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 PARD3B STOX1 MAST4 FGFR3 BCAR3	1.22e-05	200	113	6	941536b7c32f1e63c70535233b2ccce0cd7bf96e
ToppCell	Macroglial-Astrocytes-SLC14A1---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 PARD3B STOX1 MAST4 FGFR3 BCAR3	1.22e-05	200	113	6	d6fcbf4f4bc1b89a9929d7b114c6b907b6979900
ToppCell	Macroglial-Astrocytes-SLC14A1----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 PARD3B STOX1 MAST4 FGFR3 BCAR3	1.22e-05	200	113	6	f861509b54185d89931db64da1b9d81986cc7938
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABI3BP IGSF10 AFAP1 ARID5B PLEKHH2 MYO16	1.22e-05	200	113	6	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABI3BP IGSF10 AFAP1 ARID5B PLEKHH2 MYO16	1.22e-05	200	113	6	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ABI3BP IGSF10 AFAP1 ARID5B PLEKHH2 MYO16	1.22e-05	200	113	6	3bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCell	Macroglial-Astrocytes-SLC14A1\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 PARD3B STOX1 MAST4 FGFR3 BCAR3	1.22e-05	200	113	6	16f468217427921fa18c6d078ffa990eb019b257
ToppCell	Macroglial-Astrocytes-SLC14A1--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 PARD3B STOX1 MAST4 FGFR3 BCAR3	1.22e-05	200	113	6	0442894c39eec69850c090957a5dc7bcecd21e04
ToppCell	Macroglial-Astrocytes-SLC14A1-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SHROOM3 PARD3B STOX1 MAST4 FGFR3 BCAR3	1.22e-05	200	113	6	01819446deeab9054f5cfe889d53bb49d137dbc0
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW26\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	SRCIN1 SLC4A3 CCDC85A MAST4 ANKRD24 MYO16	1.22e-05	200	113	6	5c7263c862093ad9dbc81d06b16b6f74e8a6b634
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DOCK1 SLC4A3 IGSF10 FCER1A BCAR3	4.45e-05	153	113	5	91e9d70a5d3f6fd68c284ed0cc113f03d7d1e10b
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DOCK1 SLC4A3 IGSF10 FCER1A BCAR3	4.45e-05	153	113	5	f17f62646633cf95c810dcd5328978058741b276
ToppCell	NS-moderate-d_07-13-Myeloid-Mast_cell\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ABI3BP GDPD4 MAST4 FCER1A BTK	4.88e-05	156	113	5	17c38d3b03fc38cb125cf0d165b2fd694cd88edd
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOCK1 BEND5 NCKAP5 SLC4A3 FCER1A	5.03e-05	157	113	5	19c0599a669803c4db1f174de1ce755e562a50a3
ToppCell	10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	DOCK1 RAG1 RPS3 XIRP2 ZCCHC7	6.01e-05	163	113	5	edca1d1a345109dbdeb7ee5464faefab1993fdb2
ToppCell	ICU-NoSEP-Myeloid-cDC2\|ICU-NoSEP / Disease, Lineage and Cell Type	BEND5 NCKAP5 SLC4A3 FCER1A BCAR3	6.74e-05	167	113	5	5b7b731944d888591279ef6167b3ae8cab3f6886
ToppCell	Control\|World / group, cell type (main and fine annotations)	SHROOM3 MAGI3 PARD3B NCKAP5 PDZD2	6.93e-05	168	113	5	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	mild_COVID-19_(asymptomatic)-pDC\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	DOCK1 SLC4A3 IGSF10 FCER1A TTLL11	6.93e-05	168	113	5	968405ea56f7d001ef83ff9274610923c3b2d55d
ToppCell	AT1-AT2_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	PCLO MAGI3 NCKAP5 CCDC85A PEAK1	7.13e-05	169	113	5	815474855a70498a74e52f6583113c63b7267a0c
ToppCell	Control-T/NK_proliferative\|World / Disease group and Cell class	TTC28 MAGI3 ARHGAP11A C6orf136 PEAK1	7.13e-05	169	113	5	fca735cbb55fce4d32dc6632a39acea1d16b87ab
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SHROOM3 MAGI3 NCKAP5 SRCIN1 MAST4	7.33e-05	170	113	5	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RAG1 TRPC4 PAK6 BTK FGFR3	8.40e-05	175	113	5	9a96794df049d8228fea57c1584c160191d36b56
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SUPT20H CHD9 JMJD1C IGSF10 XIRP2	8.63e-05	176	113	5	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	ASK440-Immune-Mast_cell\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	SUPT20H LCP2 FCER1A BTK TRAF3IP3	9.10e-05	178	113	5	dcefc4afca3a40d1bd44722e66bca6b45a6c6c55
ToppCell	C_00\|World / shred on cell type and cluster	ATAD5 RPS3 CHD9 MLXIP DDX21	9.35e-05	179	113	5	da2dadc3266ffebd4a34ac61bfa05fddcadcde4c
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TRPC4 AFAP1 ANKRD34B KCNC1 MYO16	9.35e-05	179	113	5	d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCell	AT1_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	ABI3BP BCAT2 NCKAP5 CCDC85A PLEKHH2	9.35e-05	179	113	5	1603117b52623663458a977c94bf7f9f6c1114b8
ToppCell	AT1_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	BCAT2 NCKAP5 CCDC85A TJP1 PLEKHH2	9.60e-05	180	113	5	ff4728782c3ec814ba071cc22b7894abdd9da837
Disease	cerebral palsy (implicated_via_orthology)	AGAP5 AGAP9 AGAP7P AGAP4 AGAP6	1.29e-10	10	105	5	DOID:1969 (implicated_via_orthology)
Disease	Central Nervous System Neoplasms	APC BAP1	7.49e-05	4	105	2	C0085136
Disease	cup-to-disc ratio measurement	CNBD1 ABI3BP TTC28 RPAP3 AFAP1 ARID5B MYO16 PDZD2	1.55e-04	430	105	8	EFO_0006939
Disease	interleukin 10 measurement	SHROOM3 SUPT20H DYNC2H1 JMJD1C	1.76e-04	78	105	4	EFO_0004750
Disease	autism spectrum disorder (implicated_via_orthology)	SHANK1 SYN3 TRPC4 CHD9 WDFY3	2.17e-04	152	105	5	DOID:0060041 (implicated_via_orthology)
Disease	Prostatic Neoplasms	RAG1 EI24 APC IRS1 PAK6 FASLG BAP1 BRPF1 EIF3A	3.61e-04	616	105	9	C0033578
Disease	Malignant neoplasm of prostate	RAG1 EI24 APC IRS1 PAK6 FASLG BAP1 BRPF1 EIF3A	3.61e-04	616	105	9	C0376358
Disease	Metastatic melanoma	MAP3K10 TAF1 PEAK1	9.52e-04	54	105	3	C0278883
Disease	cortical surface area measurement	CNBD1 SHROOM3 APC PARD3B NCKAP5 STOX1 VSTM4 AFAP1 MAST4 TJP1 FGFR3 MYO16 PDZD2	9.82e-04	1345	105	13	EFO_0010736
Disease	anemia (implicated_via_orthology)	APC SLC4A3	1.28e-03	15	105	2	DOID:2355 (implicated_via_orthology)
Disease	B-cell acute lymphoblastic leukemia	CEBPE ARID5B	1.28e-03	15	105	2	EFO_0000094
Disease	Pontoneocerebellar hypoplasia	PCLO VPS53	1.46e-03	16	105	2	cv:C1261175
Disease	Malignant neoplasm of breast	XIRP1 DYNC2H1 TRPC4 ARHGAP11A BAP1 CCT5 SPATA21 BTK PAK1 BCAR3 DEK	1.55e-03	1074	105	11	C0006142
Disease	Lipidemias	APC IRS1	1.65e-03	17	105	2	C1706412
Disease	Hyperlipidemia	APC IRS1	1.65e-03	17	105	2	C0020473
Disease	Carcinoma of bladder	FGFR3 PEAK1	1.85e-03	18	105	2	C0699885
Disease	Alzheimer disease, educational attainment	BCAT2 JMJD1C TTLL11 FGFR3 BCAR3	1.93e-03	247	105	5	EFO_0011015, MONDO_0004975
Disease	hemifacial microsomia	SHROOM3 PARD3B	2.06e-03	19	105	2	MONDO_0015398
Disease	intrahepatic cholangiocarcinoma (is_marker_for)	FASLG BAP1	2.06e-03	19	105	2	DOID:4928 (is_marker_for)
Disease	coagulation factor V measurement	PAK6 MAST4	2.29e-03	20	105	2	EFO_0008087
Disease	intrinsic cardiomyopathy (implicated_via_orthology)	RPS3 CCT5	2.52e-03	21	105	2	DOID:0060036 (implicated_via_orthology)
Disease	insulin measurement	CNBD1 IRS1 JMJD1C CCDC85A KCNC1	2.70e-03	267	105	5	EFO_0004467
Disease	cholangiocarcinoma (is_implicated_in)	APC FASLG	2.77e-03	22	105	2	DOID:4947 (is_implicated_in)
Disease	transitional cell carcinoma (is_implicated_in)	APC FGFR3	2.77e-03	22	105	2	DOID:2671 (is_implicated_in)
Disease	Breast Carcinoma	DYNC2H1 BAP1 CCT5 BTK PAK1 BCAR3 DEK	3.16e-03	538	105	7	C0678222

Protein segments in the cluster

Peptide	Gene	Start	Entry
HPLKSTKEVNPPPKQ	nan	131	Q6ZRG5
KKDAVPKPPLSPHKL	BEND5	351	Q7L4P6
LNPPPSPHANKKKHL	AGAP4	366	Q96P64
AQVHPIPPKKTGKIP	ATAD5	326	Q96QE3
APVRKNHKKMPVPPG	FAM246A	211	A0A494C0Y3
KGFRLLNPHPKPNPK	FCER1A	241	P12319
KPLPSVGPHTDKSPQ	SLC4A3	186	P48751
PSHSPPTPVKKLLVG	C6orf136	281	Q5SQH8
SPKLNPPPSPHANKK	AGAP9	431	Q5VTM2
SHSELPPPGKVKLIP	C2orf78	706	A6NCI8
SPLLKAPSPAGPLHK	CEBPE	181	Q15744
KPGSSHRKTKKPLPP	BTK	176	Q06187
SIHGTLPRKKKGPPP	BCAR3	46	O75815
NFHIPKKGPPAKKPG	BAZ1B	381	Q9UIG0
PPPSSPVHKAELEKK	AFAP1	261	Q8N556
HSPPNKPKLVVKPPG	BAP1	326	Q92560
GSHGKPAPLPVPQKI	ACSM5	21	Q6NUN0
HGKQGAPKKRKAPPP	ANKRD24	296	Q8TF21
PKIQEKPKPTHKPTL	ARMCX5	201	Q6P1M9
LNPPPSPHANKKKHL	AGAP6	366	Q5VW22
GQKPVPTQPLLKAHP	RAG1	71	P15918
KDPTQKPSPHPVKPL	RAB11FIP5	516	Q9BXF6
RKPALAPKGPKLPHA	ANKRD34B	231	A5PLL1
TKVPPPVHGKSGLKT	PARD3B	316	Q8TEW8
SHKPQPTRKLPPKKD	LARP1	191	Q6PKG0
SPPPKLKNSHKVSPV	PAK6	616	Q9NQU5
PNLGKSPKHTPIAPG	MAP3K10	591	Q02779
ILTSKNKPPPGVIPH	MAGI3	866	Q5TCQ9
KAGPSAEAPKVHPKP	MYO16	1606	Q9Y6X6
TSLSKPPPLIKHQPE	JMJD1C	1141	Q15652
IFTPGPPSTPKHKKS	KCNQ3	571	O43525
KKPPPLVKQPTLHGS	PCLO	701	Q9Y6V0
QKKGVTVPHSPPQPK	PDZD2	1841	O15018
FKPKSLHQLPPDPEK	PEAK1	21	Q9H792
QPPSKAPKLHSEPSK	ISG20L2	46	Q9H9L3
PIKNAVTPLKPGKHE	GDPD4	561	Q6W3E5
LFKRPLPKSKPGSPH	MED17	276	Q9NVC6
LPHPKPPVESSGGKL	IRS1	711	P35568
KGTQLVPSSHLPPPK	PLEKHH2	426	Q8IVE3
HGSKPLPPNPEEKKK	PAK1	36	Q13153
PKPVSLTGGRPKQPH	MLXIP	541	Q9HAP2
PLPPHGKPLGKLNST	DYNC2H1	2591	Q8NCM8
PLTPNPASKKPRVHK	CHD9	2111	Q3L8U1
KTHNPGSLPTKKELP	IGSF10	1276	Q6WRI0
KKKHIPRPPQLGSPN	KCNC1	456	P48547
TVKPKLDLPPKFHRP	DOCK1	1406	Q14185
IHGLFSLSKKPPKPQ	EIF3A	256	Q14152
NFLMHPKPSGKPLPK	DEK	181	P35659
AEKFPSPHPSPAKLK	EI24	321	O14681
LNPPPSPHANKKKHL	AGAP7P	366	Q5VUJ5
DKEPKLPPKLAGPLH	ANKMY2	151	Q8IV38
PKALKGPSPEHHKPL	CCDC85A	271	Q96PX6
NVPKKPAVPLKTDHP	ENKUR	81	Q8TC29
PKHPKPSTVKDCPTL	MAST4	2331	O15021
HKKPRKDPGVPNSAP	GNL3	41	Q9BVP2
KNPIKSIPAPATKPG	KIAA1210	1416	Q9ULL0
PPKKGLGSPTVHKIS	FGFR3	401	P22607
KSPKLKNGFPHPEPD	DDX21	146	Q9NR30
PTPVQKHAIPIIKGK	DDX3Y	201	O15523
MTQKPHKKPGPGEPL	BCAT2	41	O15382
EVKPVPASPHPKHKV	PPRC1	1056	Q5VV67
PKTEKPPARKKSGHP	CNTROB	876	Q8N137
PNHSPPPSAKVKKIF	NXPH3	86	O95157
SKKPAPPHPHLNKSQ	SYN3	526	O14994
KHPIGKTQLLPTSKP	ARHGAP11A	1006	Q6P4F7
VNPFLPSTPGPKKAK	SPATA21	16	Q7Z572
QHGSPSKLPLRIPPK	NCKAP5	1361	O14513
PGPHSVQPLLKHIKK	TAF1	631	P21675
KVPPNHVGKPLLKKP	FAM98A	181	Q8NCA5
PAHPSQPKPKGLQAL	PRR36	266	Q9H6K5
PQILHPKKAVSPVSP	SPATA31A7	1306	Q8IWB4
LEKSPENSPPVKPKH	SHROOM3	436	Q8TF72
GKIGPKKPLPDHVSI	RPS3	196	P23396
LTCPFEPPKPKTKHK	CCT5	251	P48643
VKLKKVHPDLGPNPS	WHAMM	751	Q8TF30
LLPKKAVSPVSPPQH	SPATA31C1	1161	P0DKV0
VHKKAPQQAKRLPPP	SHANK1	766	Q9Y566
PPPQQTPLRKHKKKG	BRPF1	51	P55201
SPKLNPPPSPHANKK	AGAP5	386	A6NIR3
PKNPHKPTGKVLGLA	ARID5B	911	Q14865
AKKPAQTASKLPPPV	APC	1591	P25054
PPPPLHSIPNLKKSK	CNBD1	21	Q8NA66
PPTLPKPKLPKHIKD	XIRP2	2246	A4UGR9
PQILHPKKAVSPVSP	SPATA31A3	1306	Q5VYP0
PQDTPIKKPPKHHRG	TRAF3IP3	151	Q9Y228
LTPGSPPHPLNKQKH	TLX1NB	66	P0CAT3
QGTLPPKPHLVVEKP	TULP4	1276	Q9NRJ4
SKPKPVQGLCPHGKP	TTLL11	181	Q8NHH1
FGQIPKQLFKKPHPP	WDFY3	2961	Q8IZQ1
KRPPHKSKPMQTVPG	MINDY4	156	Q4G0A6
PQILHPKKAVSPVSP	SPATA31A1	1306	Q5TZJ5
TPDHKPPKAPHGQKA	SRCIN1	961	Q9C0H9
PQILHPKKAVSPVSP	SPATA31A5	1306	Q5VU36
DNPPHPGSTKPLKKV	RPAP3	421	Q9H6T3
KHPKLPATQPIPRIK	STOX1	451	Q6ZVD7
LPKAKPGTHLPQGPS	TINF2	231	Q9BSI4
GKGVKHRPPPIKLPS	SUPT20H	456	Q8NEM7
QPKKPKAPDNPFHGI	VPS53	406	Q5VIR6
SLEKQIGHPSPPPEK	FASLG	126	P48023
IGHPSPPPEKKELRK	FASLG	131	P48023
HLVKKIPKNPPSGFV	ROCK1	1311	Q13464
QHKPEALPSNTKPLP	TJP1	1231	Q07157
HPVEKKPVKVLGPSL	ZNF621	341	Q6ZSS3
HQKSQPSPVTVKPKP	TTC28	2221	Q96AY4
YHLTTKPGPPKKPKT	ZCCHC7	326	Q8N3Z6
PAKAPIAPTFHKPKL	VSTM4	256	Q8IW00
HSVKQSGQPPLKPPS	USP31	246	Q70CQ4
KPKIPLSPEVTHTKP	ABI3BP	511	Q7Z7G0
KKKPQLPPKPAHLTQ	XIRP1	1321	Q702N8
IPGHNLNKKTPPGVK	ZNF861P	21	O60384
LNKKTPPGVKPPESH	ZNF861P	26	O60384
EPLNPKPHKKKSPGE	ZNF449	306	Q6P9G9
LNHKKPSGEKQVPPI	TRPC4	116	Q9UBN4
DPGKKVKKPAPPQHF	USP36	531	Q9P275
PIGSHPKVQSPKPIT	YEATS2	566	Q9ULM3
PKKKNKHIPRPPQPG	KCNC3	556	Q14003
RSSPLPGKKPPVPKH	LCP2	296	Q13094